Abstract:AIM:To study Hepatitis B virus (HBV) infection and its association with hepatocellular carcinoma (HCC) at the miRNA level.METHODS:Three cellular models were used to investigate miRNA expression changes during HBV infection: human HepG2 hepatoblastoma cell line as a model without HBV infection; HepG2 cell line transfected with a 1.3-fold full-length HBV genome as an acute infection model; and HepG2.2.15 cell line, which is derived from HepG2 and stably transfected with a complete HBV genome, as a chronic infection model. The miRNA levels were examined using microarray technology. To explore the relationship between HBV infection and HCC genesis at the miRNA level, we downloaded from national center for biotechnology information Gene Expression Omnibus an miRNA expression dataset derived from HCC patients, most of whom are HBV carriers. We compared the miRNA expression alterations during HBV infection with those in HCC patients, by analyzing miRNA expression change profiles statistically.RESULTS:Seventy-seven and 48 miRNAs were differentially expressed during acute and chronic HBV infection, respectively. Among these miRNAs, 25 were in common, the intersection of which was significant under the hypergeometric test (P = 1.3 × 10⁻¹¹). Fourteen miRNAs were observed to change coherently in the acute and chronic infections, with one upregulated and 13 downregulated. Eleven showed inverse changes during the two phases of infection; downregulated in the acute infection and upregulated in the chronic infection. The results imply that common and specific mechanisms exist at the miRNA level during acute and chronic HBV infection. Besides, comparative analysis of the miRNA expression changes during HBV infection with those in HCC indicates that, although miRNA expression changes during HBV infection are distinct from those in HCC patients (P < 2.2 × 10⁻¹⁶), they exhibited significant correlations (P = 0.0229 for acute infection; P = 0.0084 for chronic infection). Perturbation of miRNA expression during chronic HBV infection was closer to that in HCC patients than that during acute HBV infection. This observation implies the contribution of miRNAs to HCC genesis from HBV infection. According to their patterns of differential expression in acute and chronic HBV infection, as well as in HCC, miRNAs of potential research interest could be identified, such as miR-18a/miR-18b, miR-106a, miR-221 and miR-101. For instance, the gradient expression alteration of miR-221 in the above three phases, which is downregulated in acute HBV infection, normally expressed in chronic HBV infection, and upregulated in HCC, indicates that it may be a key effector for progression of the disease.CONCLUSION:Our analysis provides insights into HBV infection and related HCC in relation to miRNAs, and reveals some candidate miRNAs for future studies.

Hepatitis B Virus Promotes Cancer Cell Migration by Downregulating Mir-340-5p Expression to Induce STAT3 Overexpression.

MicroRNA-302d Downregulates TGFBR2 Expression and Promotes Hepatocellular Carcinoma Growth and Invasion.

The Role of Mir-99B in Mediating Hepatocellular Carcinoma Invasion and Migration.

MicroRNA Profile in HBV-induced Infection and Hepatocellular Carcinoma.

Hepatitis B Virus P Protein Initiates Glycolytic Bypass in HBV-related Hepatocellular Carcinoma Via a FOXO3/miRNA-30b-5p/MINPP1 Axis

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Hepatitis B Virus X Protein Represses Mirna-148 a to Enhance Tumorigenesis

Mir-146A is Directly Regulated by STAT3 in Human Hepatocellular Carcinoma Cells and Involved in Anti-Tumor Immune Suppression.

Hepatitis B Viral RNA Directly Mediates Down-regulation of the Tumor Suppressor MicroRNA miR-15a/miR-16-1 in Hepatocytes

miR-515-5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway

mirRNA-365b promotes hepatocellular carcinoma cell migration and invasion by downregulating SGTB.

Hbx Elevates Oncoprotein Aeg-1 Expression to Promote Cell Migration by Downregulating Mir-375 and Mir-136 in Malignant Hepatocytes

Elevated Hmgb1 Expression Induced By Hepatitis B Virus X Protein Promotes Epithelial-Mesenchymal Transition And Angiogenesis Through Stat3/Mir-34a/Nf-Kappa B In Primary Liver Cancer

Mir-532-3p Promotes Hepatocellular Carcinoma Progression by Targeting PTPRT.

Hepatitis B Virus and Hepatocellular Carcinoma at the Mirna Level.

Mir-106B-5p Promotes Stem Cell-Like Properties of Hepatocellular Carcinoma Cells by Targeting PTEN Via PI3K/Akt Pathway

The miR-590-3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma

Poly(A)-specific ribonuclease protein promotes the proliferation, invasion and migration of esophageal cancer cells

Aberrant expression of two miRNAs promotes proliferation, hepatitis B virus amplification, migration and invasion of hepatocellular carcinoma cells: evidence from bioinformatic analysis and experimental validation

Upregulation of DARS2 by HBV Promotes Hepatocarcinogenesis Through the Mir-30E-5p/mapk/nfat5 Pathway